Qube Research & Technologies (QRT)’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-16,307
| Closed | -$420K | – | 4038 |
|
|
2025
Q3 | $420K | Buy |
+16,307
| New | +$401K | ﹤0.01% | 2759 |
|
|
2025
Q1 | – | Sell |
-84,039
| Closed | -$1.58M | – | 3843 |
|
|
2024
Q4 | $1.58M | Sell |
84,039
-276,166
| -77% | -$4.85M | ﹤0.01% | 1976 |
|
|
2024
Q3 | $5.42M | Buy |
360,205
+231,014
| +179% | +$3.95M | 0.01% | 1349 |
|
|
2024
Q2 | $3.7M | Buy |
+129,191
| New | +$3.68M | 0.01% | 1399 |
|
|
2023
Q4 | – | Sell |
-17,807
| Closed | -$546K | – | 4647 |
|
|
2023
Q3 | $546K | Buy |
+17,807
| New | +$642K | ﹤0.01% | 1993 |
|
|
2023
Q2 | – | Sell |
-37,010
| Closed | -$1.51M | – | 2849 |
|
|
2023
Q1 | $1.51M | Sell |
37,010
-15,694
| -30% | -$624K | 0.01% | 1129 |
|
|
2022
Q4 | $2.03M | Buy |
+52,704
| New | +$2.56M | 0.01% | 944 |
|
|
2022
Q3 | – | Sell |
-23,754
| Closed | -$1.39M | – | 2876 |
|
|
2022
Q2 | $1.39M | Buy |
+23,754
| New | +$1.56M | 0.01% | 973 |
|
|
2022
Q1 | – | Sell |
-7,798
| Closed | -$469K | – | 2859 |
|
|
2021
Q4 | $469K | Sell |
7,798
-768
| -9% | -$42.3K | ﹤0.01% | 1605 |
|
|
2021
Q3 | $480K | Sell |
8,566
-32
| -0.4% | -$1.84K | 0.01% | 1231 |
|
|
2021
Q2 | $522K | Buy |
8,598
+3,852
| +81% | +$244K | 0.01% | 1269 |
|
|
2021
Q1 | $333K | Buy |
+4,746
| New | +$339K | 0.01% | 1405 |
|
|
2020
Q3 | – | Sell |
-14,329
| Closed | -$752K | – | 2009 |
|
|
2020
Q2 | $752K | Buy |
+14,329
| New | +$599K | 0.01% | 962 |
|
|
2020
Q1 | – | Sell |
-13,402
| Closed | -$607K | – | 1515 |
|
|
2019
Q4 | $607K | Buy |
+13,402
| New | +$569K | 0.02% | 858 |
|
Other funds holding PCRX
DPCM
